Rozental, Alon
Halperin, Erez
Leibovitch, Chiya
Barzili, Meirav
Michowitz, Maya Koren-
Duek, Adrian
Rozovski, Uri
Extermann, Martine
Raanani, Pia
Shacham-Abulafia, Adi
Funding for this research was provided by:
Tel Aviv University
Article History
Received: 1 March 2024
Accepted: 31 May 2024
First Online: 11 June 2024
Declarations
:
: This study was conducted in accordance with the Declaration of Helsinki principles. Exemptions from requiring ethical approval were obtained from the local Ethics Committees of the four participating centers in Israel and the MCC in the USA. Owing to the retrospective nature of the study, informed consent was waived by all Institutional Review Boards (IRB).
: Adi Shacham Abulafia has received honoraria for serving on Novartis's advisory board and providing consultancy services. Pia Raanani has received honoraria for serving on:All other authors declare they have no financial interests.
: Pia Raanani is editor-in-Chief of ACTA HAEMATOLOGICA and receives no compensation. For all other authors: nothing to declare.
: The authors declare no competing interests.